Insight on Bacterial Newborn Meningitis Using a Neurovascular-Unit-on-a-Chip

The interactions of newborn meningitis (NBM) with the neurovascular unit are very complex and are hard to study. This work presents a new platform to study NBM in a system that enables monitoring of multicellular interactions and identifies processes that were not observed before. ABSTRACT Understanding the pathogenesis of bacterial infections is critical for combatting them. For some infections, animal models are inadequate and functional genomic studies are not possible. One example is bacterial meningitis, a life-threatening infection with high mortality and morbidity. Here, we used the newly developed, physiologically relevant, organ-on-a-chip platform integrating the endothelium with neurons, closely mimicking in vivo conditions. Using high-magnification microscopy, permeability measurements, electrophysiological recordings, and immunofluorescence staining, we studied the dynamic by which the pathogens cross the blood-brain barrier and damage the neurons. Our work opens up possibilities for performing large-scale screens with bacterial mutant libraries for identifying the virulence genes involved in meningitis and determining the role of these genes, including various capsule types, in the infection process. These data are essential for understanding and therapy of bacterial meningitis. Moreover, our system offers possibilities for the study of additional infections—bacterial, fungal, and viral. IMPORTANCE The interactions of newborn meningitis (NBM) with the neurovascular unit are very complex and are hard to study. This work presents a new platform to study NBM in a system that enables monitoring of multicellular interactions and identifies processes that were not observed before.

[1]  Y. Bahn,et al.  Pathogens infecting the central nervous system , 2022, PLoS pathogens.

[2]  Ben M. Maoz Brain-on-a-Chip: Characterizing the next generation of advanced in vitro platforms for modeling the central nervous system , 2021, APL bioengineering.

[3]  Ben M. Maoz,et al.  Biology and Models of the Blood-Brain Barrier. , 2021, Annual review of biomedical engineering.

[4]  F. Iovino,et al.  Neuronal Damage and Neuroinflammation, a Bridge Between Bacterial Meningitis and Neurodegenerative Diseases , 2021, Frontiers in Cellular Neuroscience.

[5]  Ben M. Maoz,et al.  Transforming a well into a chip: A modular 3D-printed microfluidic chip , 2021, APL bioengineering.

[6]  Ben M. Maoz,et al.  Effect of SARS-CoV-2 proteins on vascular permeability , 2021, bioRxiv.

[7]  F. Gomes,et al.  Ethanol Gestational Exposure Impairs Vascular Development and Endothelial Potential to Control BBB-Associated Astrocyte Function in the Developing Cerebral Cortex , 2021, Molecular Neurobiology.

[8]  Rossana Rauti,et al.  Recent progress in translational engineered in vitro models of the central nervous system , 2020, Brain : a journal of neurology.

[9]  Kayoko Yamada,et al.  Overcoming the Challenges of Megabase-Sized Plasmid Construction in Escherichia coli. , 2020, ACS synthetic biology.

[10]  M. Prato,et al.  Tuning Neuronal Circuit Formation in 3D Polymeric Scaffolds by Introducing Graphene at the Bio/Material Interface , 2020, Advanced biosystems.

[11]  L. Ballerini,et al.  Bilirubin disrupts calcium homeostasis in neonatal hippocampal neurons: a new pathway of neurotoxicity , 2020, Archives of Toxicology.

[12]  Weijia Wen,et al.  Organ-on-a-chip: recent breakthroughs and future prospects , 2020, BioMedical Engineering OnLine.

[13]  D. Biran,et al.  Escherichia coli O-antigen Capsule (Group 4) is Essential for Serum Resistance. , 2020, Research in microbiology.

[14]  C. Schwerk,et al.  Virulence Factors of Meningitis-Causing Bacteria: Enabling Brain Entry across the Blood–Brain Barrier , 2019, International journal of molecular sciences.

[15]  R. Cohen,et al.  Combination therapy with ciprofloxacin and third-generation cephalosporin versus third-generation cephalosporin monotherapy in Escherichia coli meningitis in infants: a multicentre propensity score-matched observational study. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  M. Prato,et al.  Chemically Cross-Linked Carbon Nanotube Films Engineered to Control Neuronal Signaling. , 2019, ACS nano.

[17]  D. Scaini,et al.  Carbon Nanotubes, Directly Grown on Supporting Surfaces, Improve Neuronal Activity in Hippocampal Neuronal Networks , 2019, Advanced biosystems.

[18]  V. Masignani,et al.  The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology , 2019, Front. Immunol..

[19]  R. Rappuoli,et al.  Meningococcal B vaccine (4CMenB): the journey from research to real world experience , 2018, Expert review of vaccines.

[20]  M. Mohammadi,et al.  Fullerenol Nanoparticles Decrease Blood-Brain Barrier Interruption and Brain Edema during Cerebral Ischemia-Reperfusion Injury Probably by Reduction of Interleukin-6 and Matrix Metalloproteinase-9 Transcription. , 2018, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[21]  Huanchun Chen,et al.  New insights into meningitic Escherichia coli infection of brain microvascular endothelial cells from quantitative proteomics analysis , 2018, Journal of Neuroinflammation.

[22]  Huanchun Chen,et al.  New insights into meningitic Escherichia coli infection of brain microvascular endothelial cells from quantitative proteomics analysis , 2018, Journal of Neuroinflammation.

[23]  Qihan Li,et al.  miR-1303 regulates BBB permeability and promotes CNS lesions following CA16 infections by directly targeting MMP9 , 2018, Emerging Microbes & Infections.

[24]  Bo Li,et al.  Caspr1 is a host receptor for meningitis-causing Escherichia coli , 2018, Nature Communications.

[25]  D. Conway,et al.  Characterization of cell-cell junction changes associated with the formation of a strong endothelial barrier , 2018, Tissue barriers.

[26]  J. O’Donnell,et al.  Targeting von Willebrand Factor-Mediated Inflammation. , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[27]  P. Lenting,et al.  von Willebrand factor and inflammation , 2017, Journal of thrombosis and haemostasis : JTH.

[28]  G. Limongelli,et al.  The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy , 2017, Mediators of inflammation.

[29]  Sean P. Palecek,et al.  An isogenic blood–brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells , 2017, Journal of neurochemistry.

[30]  B. Stoll,et al.  Emergence of Antibiotic Resistance-Associated Clones Among Escherichia coli Recovered From Newborns With Early-Onset Sepsis and Meningitis in the United States, 2008-2009. , 2016, Journal of the Pediatric Infectious Diseases Society.

[31]  Huanchun Chen,et al.  Induction of VEGFA and Snail-1 by meningitic Escherichia coli mediates disruption of the blood-brain barrier , 2016, Oncotarget.

[32]  L. Boyer Escherichia coli K1 meningitis: Analysis of the effects of CNF1 toxin in newborn mice questions its virulence function. , 2016, Virulence.

[33]  K. Kim Human Meningitis-Associated Escherichia coli , 2016, EcoSal Plus.

[34]  Mandy B. Esch,et al.  TEER Measurement Techniques for In Vitro Barrier Model Systems , 2015, Journal of laboratory automation.

[35]  K. Danker,et al.  Interleukin-1β induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood–brain barrier model , 2014, Journal of Neuroscience Methods.

[36]  G. Hatch,et al.  The Blood Brain Barrier — Regulation of Fatty Acid and Drug Transport , 2014 .

[37]  M. Vizcaychipi,et al.  Neuroinflammation: The role and consequences , 2014, Neuroscience Research.

[38]  Ron Milo,et al.  Spanning high-dimensional expression space using ribosome-binding site combinatorics , 2013, Nucleic acids research.

[39]  Kapil Pant,et al.  SyM-BBB: a microfluidic Blood Brain Barrier model. , 2013, Lab on a chip.

[40]  A. Berg,et al.  BBB ON CHIP: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function , 2013, Biomedical microdevices.

[41]  Chulhee Choi,et al.  Reliable permeability assay system in a microfluidic device mimicking cerebral vasculatures , 2012, Biomedical microdevices.

[42]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[43]  Hanseup Kim,et al.  Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB). , 2012, Lab on a chip.

[44]  Dora Brites,et al.  Looking at the blood–brain barrier: Molecular anatomy and possible investigation approaches , 2010, Brain Research Reviews.

[45]  N. Prasadarao,et al.  BRAIN DAMAGE IN NEWBORN RAT MODEL OF MENINGITIS BY ENTEROBACTER SAKAZAKII: A ROLE FOR OUTER MEMBRANE PROTEIN A , 2009, Laboratory Investigation.

[46]  K. Kim Mechanisms of microbial traversal of the blood–brain barrier , 2008, Nature Reviews Microbiology.

[47]  P. Fratamico,et al.  Extraintestinal pathogenic Escherichia coli. , 2007, Foodborne pathogens and disease.

[48]  Karl Herrup,et al.  Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? , 2007, Nature Reviews Neuroscience.

[49]  Munhyang Lee,et al.  Effects of dopamine infusion on cerebral blood flow, brain cell membrane function and energy metabolism in experimental Escherichia coli meningitis in the newborn piglet. , 2003, Journal of Korean medical science.

[50]  K. Kim Neurological diseases: Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury , 2003, Nature Reviews Neuroscience.

[51]  H. Pfister,et al.  Pathophysiology of bacterial meningitis: mechanism(s) of neuronal injury. , 2002, The Journal of infectious diseases.

[52]  K. Kim Escherichia coli Translocation at the Blood-Brain Barrier , 2001, Infection and Immunity.

[53]  U. Gophna,et al.  Curli Fibers Mediate Internalization ofEscherichia coli by Eukaryotic Cells , 2001, Infection and Immunity.

[54]  A. Jong,et al.  Further characterization of Escherichia coli brain microvascular endothelial cell invasion gene ibeA by deletion, complementation, and protein expression. , 2001, The Journal of infectious diseases.

[55]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[56]  J. R. Johnson,et al.  Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. , 2000, The Journal of infectious diseases.

[57]  Ying Wang,et al.  The Gene Locus yijP Contributes to Escherichia coli K1 Invasion of Brain Microvascular Endothelial Cells , 1999, Infection and Immunity.

[58]  Ying Wang,et al.  Identification and Characterization of an Escherichia coli Invasion Gene Locus, ibeB, Required for Penetration of Brain Microvascular Endothelial Cells , 1999, Infection and Immunity.

[59]  J. Hacker,et al.  Virulence patterns from septicemic Escherichia coli O78 strains. , 1997, FEMS microbiology letters.

[60]  R. van Furth,et al.  Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy , 1996, Infection and immunity.

[61]  N. Prasadarao,et al.  Escherichia coli invasion of brain microvascular endothelial cells in vitro and in vivo: molecular cloning and characterization of invasion gene ibe10 , 1995, Infection and immunity.

[62]  H. Pfister,et al.  Mechanisms of brain injury in bacterial meningitis: workshop summary. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[63]  A. Cross,et al.  The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat. , 1992, The Journal of clinical investigation.

[64]  V. Lorenzo,et al.  Aerobactin production as a virulence factor: A reevaluation , 1988, European Journal of Clinical Microbiology and Infectious Diseases.

[65]  R. Wirth,et al.  Transformation of bacteria with plasmid DNA by electroporation. , 1988, Analytical biochemistry.

[66]  B. Paw,et al.  Aerobactin biosynthesis and transport genes of plasmid ColV-K30 in Escherichia coli K-12 , 1986, Journal of bacteriology.

[67]  S. Falkow,et al.  A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12 , 1985, Nature.

[68]  R. Firth Function , 1955, Yearbook of Anthropology.

[69]  Ben M. Maoz,et al.  Spatial Trans-Epithelial Electrical Resistance (S-TEER) Integrated in Organs-on-Chips , 2021, Lab on a Chip.

[70]  K. Kim Acute bacterial meningitis in infants and children. , 2010, The Lancet. Infectious diseases.

[71]  I. Roberts,et al.  Capsular polysaccharides in Escherichia coli. , 2008, Advances in applied microbiology.

[72]  B. Moser,et al.  Cytokines and chemokines in meningeal inflammation: biology and clinical implications. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[73]  L. Drury,et al.  Transformation of bacteria by electroporation. , 1996, Methods in molecular biology.

[74]  H. Milch,et al.  Escherichia coli Col V plasmids and their role in pathogenicity. , 1984, Acta microbiologica Hungarica.

[75]  H. Milch,et al.  Characterization of Escherichia coli serogroups causing meningitis, sepsis and enteritis. II. Classification of Escherichia coli O78 strains by phage sensitivity, colicin type and antibiotic resistance. , 1977, Acta microbiologica Academiae Scientiarum Hungaricae.